Literature DB >> 11959855

A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases.

Steven J Kridel1, Hisako Sawai, Boris I Ratnikov, Emily I Chen, Weizhong Li, Adam Godzik, Alex Y Strongin, Jeffrey W Smith.   

Abstract

In our study, we characterized the substrate recognition properties of membrane type-1 matrix metalloproteinase (MT1-MMP; also known as MMP-14), a key enzyme in tumor cell invasion and metastasis. A panel of optimal peptide substrates for MT1-MMP was identified using substrate phage display. The substrates can be segregated into four groups based on their degree of selectivity for MT1-MMP. Substrates with poor selectivity for MT1-MMP are comprised predominately of the Pro-X-X- downward arrow-X(Hy) motif that is recognized by a number of MMPs. Highly selective substrates lack the characteristic Pro at the P(3) position; instead they contain an Arg at the P(4) position. This P(4) Arg is essential for efficient hydrolysis and for selectivity for MT1-MMP. Molecular modeling indicates that the selective substrates adopt a linear conformation that extends along the entire catalytic pocket of MT1-MMP, whereas non-selective substrates are kinked at the conserved P(3) Pro residue. Importantly, the selective substrates can be made non-selective by insertion of a proline kink at P(3), without significantly reducing overall k(cat)/K(m) values. Altogether the study provides a structural basis for selective and non-selective substrate recognition by MT1-MMP. The findings in this report are likely to explain several aspects of MT1-MMP biology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959855     DOI: 10.1074/jbc.M111574200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Using fluorogenic peptide substrates to assay matrix metalloproteinases.

Authors:  G B Fields
Journal:  Methods Mol Biol       Date:  2001

2.  Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.

Authors:  Francis G Spinale; Rupak Mukherjee; Juozas A Zavadzkas; Christine N Koval; Shenikqua Bouges; Robert E Stroud; Lawrence W Dobrucki; Albert J Sinusas
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

3.  Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.

Authors:  Michael R Zile; Catalin F Baicu; Robert E Stroud; An Van Laer; Jazmine Arroyo; Rupak Mukherjee; Jeffrey A Jones; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

4.  Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis.

Authors:  Sergey A Shiryaev; Piotr Cieplak; Alexander E Aleshin; Qing Sun; Wenhong Zhu; Khatereh Motamedchaboki; Alexander Sloutsky; Alex Y Strongin
Journal:  FEBS J       Date:  2011-08-08       Impact factor: 5.542

5.  In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity.

Authors:  Lei Zhu; Fan Zhang; Ying Ma; Gang Liu; Kwangmeyung Kim; Xuexun Fang; Seulki Lee; Xiaoyuan Chen
Journal:  Mol Pharm       Date:  2011-11-01       Impact factor: 4.939

6.  A comparison of human mesenchymal stem cell osteogenesis in poly(ethylene glycol) hydrogels as a function of MMP-sensitive crosslinker and crosslink density in chemically defined medium.

Authors:  Aaron H Aziz; Stephanie J Bryant
Journal:  Biotechnol Bioeng       Date:  2019-03-05       Impact factor: 4.530

7.  Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases.

Authors:  Hsueh-Liang Fu; Anjum Sohail; Rajeshwari R Valiathan; Benjamin D Wasinski; Malika Kumarasiri; Kiran V Mahasenan; M Margarida Bernardo; Dorota Tokmina-Roszyk; Gregg B Fields; Shahriar Mobashery; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

8.  Identification of highly selective MMP-14 inhibitory Fabs by deep sequencing.

Authors:  Tyler Lopez; Dong Hyun Nam; Evan Kaihara; Zahid Mustafa; Xin Ge
Journal:  Biotechnol Bioeng       Date:  2017-02-20       Impact factor: 4.530

9.  Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.

Authors:  Maciej J Stawikowski; Roma Stawikowska; Gregg B Fields
Journal:  Biochemistry       Date:  2015-05-05       Impact factor: 3.162

10.  Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity.

Authors:  J Oliver McIntyre; Barbara Fingleton; K Sam Wells; David W Piston; Conor C Lynch; Shiva Gautam; Lynn M Matrisian
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.